Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Plasma Protease C1-inhibitor Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Takeda Pharmaceutical Company Limited
Pharming Technologies BV
CSL Behring LLC
Centogene AG
Ionis Pharmaceuticals, Inc
BioCryst Pharmaceuticals
By Type:
Kallikrein Inhibitor (Kalbitor)
C1-inhibitors
By Application:
Independent Pharmacies and Outlets
Hospital Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Plasma Protease C1-inhibitor Treatment Market Overview 2018-2029
-
1.1 China Plasma Protease C1-inhibitor Treatment Industry Development Overview
-
1.2 China Plasma Protease C1-inhibitor Treatment Industry Development History
-
1.3 China Plasma Protease C1-inhibitor Treatment Industry Market Size (2018-2029)
-
1.4 China Plasma Protease C1-inhibitor Treatment Market Analysis by Type from Production Side
-
1.4.1 China Plasma Protease C1-inhibitor Treatment Production Volume, Production Value and Growth Rate of Kallikrein Inhibitor (Kalbitor) (2018-2029)
-
1.4.2 China Plasma Protease C1-inhibitor Treatment Production Volume, Production Value and Growth Rate of C1-inhibitors (2018-2029)
-
1.5 China Plasma Protease C1-inhibitor Treatment Market Analysis by Application from Consumption End
-
1.5.1 China Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate of Independent Pharmacies and Outlets (2018-2029)
-
1.5.2 China Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.6 China Plasma Protease C1-inhibitor Treatment Market Analysis by Region
-
1.6.1 North China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
Chapter 2 China Plasma Protease C1-inhibitor Treatment Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Plasma Protease C1-inhibitor Treatment Market Status and Competition at home and abroad in 2023
-
2.2.2 China Plasma Protease C1-inhibitor Treatment Market Status and Competition Analysis in 2023
-
2.2.3 China Plasma Protease C1-inhibitor Treatment Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Plasma Protease C1-inhibitor Treatment Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Plasma Protease C1-inhibitor Treatment Industry Development
Chapter 3 Plasma Protease C1-inhibitor TreatmentIndustry Chain Analysis
-
3.1 Plasma Protease C1-inhibitor Treatment Industry Chain
-
3.2 Plasma Protease C1-inhibitor Treatment Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Plasma Protease C1-inhibitor Treatment Market
-
3.3 Plasma Protease C1-inhibitor Treatment Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Plasma Protease C1-inhibitor Treatment Market
Chapter 4 China Plasma Protease C1-inhibitor Treatment Market, by Type
-
4.1 China Plasma Protease C1-inhibitor Treatment Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Plasma Protease C1-inhibitor Treatment Total Production Volume and Growth Rate from Production Side
-
4.5 China Plasma Protease C1-inhibitor Treatment Production Volume and Growth Rate, by Type
-
4.5.1 China Plasma Protease C1-inhibitor Treatment Production Volume and Growth Rate of Kallikrein Inhibitor (Kalbitor)
-
4.5.2 China Plasma Protease C1-inhibitor Treatment Production Volume and Growth Rate of C1-inhibitors
Chapter 5 China Plasma Protease C1-inhibitor Treatment Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Plasma Protease C1-inhibitor Treatment Total Market Size and Growth Rate from Consumption End
-
5.5 China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate, by Application
-
5.5.1 China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Independent Pharmacies and Outlets
-
5.5.2 China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Hospital Pharmacies
Chapter 6 China Plasma Protease C1-inhibitor Treatment Market, by Region
-
6.1 China Plasma Protease C1-inhibitor Treatment Production Volume and Production Value, by Region
-
6.2 China Plasma Protease C1-inhibitor Treatment Sales Volume and Sales Value, by Region
Chapter 7 North China Plasma Protease C1-inhibitor Treatment Market Analysis
-
7.1 North China Plasma Protease C1-inhibitor Treatment Market, by Type
-
7.2 North China Plasma Protease C1-inhibitor Treatment Market, by Application
Chapter 8 Central China Plasma Protease C1-inhibitor Treatment Market Analysis
-
8.1 Central China Plasma Protease C1-inhibitor Treatment Market, by Type
-
8.2 Central China Plasma Protease C1-inhibitor Treatment Market, by Application
Chapter 9 South China Plasma Protease C1-inhibitor Treatment Market Analysis
-
9.1 South China Plasma Protease C1-inhibitor Treatment Market, by Type
-
9.2 South China Plasma Protease C1-inhibitor Treatment Market, by Application
Chapter 10 East China Plasma Protease C1-inhibitor Treatment Market Analysis
-
10.1 East China Plasma Protease C1-inhibitor Treatment Market, by Type
-
10.2 East China Plasma Protease C1-inhibitor Treatment Market, by Application
Chapter 11 Northeast China Plasma Protease C1-inhibitor Treatment Market Analysis
-
11.1 Northeast China Plasma Protease C1-inhibitor Treatment Market, by Type
-
11.2 Northeast China Plasma Protease C1-inhibitor Treatment Market, by Application
Chapter 12 Southwest China Plasma Protease C1-inhibitor Treatment Market Analysis
-
12.1 Southwest China Plasma Protease C1-inhibitor Treatment Market, by Type
-
12.2 Southwest China Plasma Protease C1-inhibitor Treatment Market, by Application
Chapter 13 Northwest China Plasma Protease C1-inhibitor Treatment Market Analysis
-
13.1 Northwest China Plasma Protease C1-inhibitor Treatment Market, by Type
-
13.2 Northwest China Plasma Protease C1-inhibitor Treatment Market, by Application
Chapter 14 Company Profiles
-
14.1 Takeda Pharmaceutical Company Limited
-
14.1.1 Takeda Pharmaceutical Company Limited Company Profile
-
14.1.2 Takeda Pharmaceutical Company Limited Plasma Protease C1-inhibitor Treatment Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Pharming Technologies BV
-
14.2.1 Pharming Technologies BV Company Profile
-
14.2.2 Pharming Technologies BV Plasma Protease C1-inhibitor Treatment Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 CSL Behring LLC
-
14.3.1 CSL Behring LLC Company Profile
-
14.3.2 CSL Behring LLC Plasma Protease C1-inhibitor Treatment Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Centogene AG
-
14.4.1 Centogene AG Company Profile
-
14.4.2 Centogene AG Plasma Protease C1-inhibitor Treatment Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Ionis Pharmaceuticals, Inc
-
14.5.1 Ionis Pharmaceuticals, Inc Company Profile
-
14.5.2 Ionis Pharmaceuticals, Inc Plasma Protease C1-inhibitor Treatment Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 BioCryst Pharmaceuticals
-
14.6.1 BioCryst Pharmaceuticals Company Profile
-
14.6.2 BioCryst Pharmaceuticals Plasma Protease C1-inhibitor Treatment Market Performance
-
14.6.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Plasma Protease C1-inhibitor Treatment Industry Research Conclusions
-
15.2 Plasma Protease C1-inhibitor Treatment Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Plasma Protease C1-inhibitor Treatment Industry Market Size (2018-2029)
-
Figure China Plasma Protease C1-inhibitor Treatment Production Volume, Production Value and Growth Rate of Kallikrein Inhibitor (Kalbitor) (2018-2029)
-
Figure China Plasma Protease C1-inhibitor Treatment Production Volume, Production Value and Growth Rate of C1-inhibitors (2018-2029)
-
Figure China Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate of Independent Pharmacies and Outlets (2018-2029)
-
Figure China Plasma Protease C1-inhibitor Treatment Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure North China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
Figure Central China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
Figure South China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
Figure East China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate from 2018-2029
-
Figure Plasma Protease C1-inhibitor Treatment Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Plasma Protease C1-inhibitor Treatment Market Share by Type in 2018
-
Figure China Plasma Protease C1-inhibitor Treatment Market Share by Type in 2023
-
Figure China Plasma Protease C1-inhibitor Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Plasma Protease C1-inhibitor Treatment Production Volume and Growth Rate of Kallikrein Inhibitor (Kalbitor) (2018-2023)
-
Figure China Plasma Protease C1-inhibitor Treatment Production Volume and Growth Rate of C1-inhibitors (2018-2023)
-
Figure China Plasma Protease C1-inhibitor Treatment Market Share by Application in 2018
-
Figure China Plasma Protease C1-inhibitor Treatment Market Share by Application in 2023
-
Figure China Plasma Protease C1-inhibitor Treatment Total Market Size and Growth Rate from Consumption End
-
Figure China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Independent Pharmacies and Outlets (2018-2023)
-
Figure China Plasma Protease C1-inhibitor Treatment Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Table China Plasma Protease C1-inhibitor Treatment Production Volume by Region (2018-2023)
-
Table China Plasma Protease C1-inhibitor Treatment Production Volume Share by Region (2018-2023)
-
Figure China Plasma Protease C1-inhibitor Treatment Production Volume Share by Region (2018-2023)
-
Table China Plasma Protease C1-inhibitor Treatment Production Value by Region (2018-2023)
-
Table China Plasma Protease C1-inhibitor Treatment Production Value Share by Region (2018-2023)
-
Figure China Plasma Protease C1-inhibitor Treatment Production Value Share by Region (2018-2023)
-
Table China Plasma Protease C1-inhibitor Treatment Sales Volume by Region (2018-2023)
-
Table China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Region (2018-2023)
-
Figure China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Region (2018-2023)
-
Table China Plasma Protease C1-inhibitor Treatment Sales Value by Region (2018-2023)
-
Table China Plasma Protease C1-inhibitor Treatment Sales Value Share by Region (2018-2023)
-
Figure China Plasma Protease C1-inhibitor Treatment Sales Value Share by Region (2018-2023)
-
Table North China Plasma Protease C1-inhibitor Treatment Production Volume by Type (2018-2023)
-
Table North China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Figure North China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Table North China Plasma Protease C1-inhibitor Treatment Sales Volume by Application (2018-2023)
-
Table North China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Figure North China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Table Central China Plasma Protease C1-inhibitor Treatment Production Volume by Type (2018-2023)
-
Table Central China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Figure Central China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Table Central China Plasma Protease C1-inhibitor Treatment Sales Volume by Application (2018-2023)
-
Table Central China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Figure Central China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Table South China Plasma Protease C1-inhibitor Treatment Production Volume by Type (2018-2023)
-
Table South China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Figure South China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Table South China Plasma Protease C1-inhibitor Treatment Sales Volume by Application (2018-2023)
-
Table South China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Figure South China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Table East China Plasma Protease C1-inhibitor Treatment Production Volume by Type (2018-2023)
-
Table East China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Figure East China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Table East China Plasma Protease C1-inhibitor Treatment Sales Volume by Application (2018-2023)
-
Table East China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Figure East China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Table Northeast China Plasma Protease C1-inhibitor Treatment Production Volume by Type (2018-2023)
-
Table Northeast China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Figure Northeast China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Table Northeast China Plasma Protease C1-inhibitor Treatment Sales Volume by Application (2018-2023)
-
Table Northeast China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Table Southwest China Plasma Protease C1-inhibitor Treatment Production Volume by Type (2018-2023)
-
Table Southwest China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Figure Southwest China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Table Southwest China Plasma Protease C1-inhibitor Treatment Sales Volume by Application (2018-2023)
-
Table Southwest China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Table Northwest China Plasma Protease C1-inhibitor Treatment Production Volume by Type (2018-2023)
-
Table Northwest China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Figure Northwest China Plasma Protease C1-inhibitor Treatment Production Volume Share by Type (2018-2023)
-
Table Northwest China Plasma Protease C1-inhibitor Treatment Sales Volume by Application (2018-2023)
-
Table Northwest China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Plasma Protease C1-inhibitor Treatment Sales Volume Share by Application (2018-2023)
-
Table Takeda Pharmaceutical Company Limited Company Profile
-
Table Takeda Pharmaceutical Company Limited Plasma Protease C1-inhibitor Treatment Revenue, Price and Gross (2018-2023)
-
Table Pharming Technologies BV Company Profile
-
Table Pharming Technologies BV Plasma Protease C1-inhibitor Treatment Revenue, Price and Gross (2018-2023)
-
Table CSL Behring LLC Company Profile
-
Table CSL Behring LLC Plasma Protease C1-inhibitor Treatment Revenue, Price and Gross (2018-2023)
-
Table Centogene AG Company Profile
-
Table Centogene AG Plasma Protease C1-inhibitor Treatment Revenue, Price and Gross (2018-2023)
-
Table Ionis Pharmaceuticals, Inc Company Profile
-
Table Ionis Pharmaceuticals, Inc Plasma Protease C1-inhibitor Treatment Revenue, Price and Gross (2018-2023)
-
Table BioCryst Pharmaceuticals Company Profile
-
Table BioCryst Pharmaceuticals Plasma Protease C1-inhibitor Treatment Revenue, Price and Gross (2018-2023)
-
